Why Choose NeuroStar?

To view all efficacy and safety information, please click (more info). The video presented includes testimonials from physicians providing FDA-cleared NeuroStar TMS Therapy.®

Before viewing, please note below the FDA-cleared indication for use and clinical trials data for NeuroStar TMS Therapy.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.

Efficacy for NeuroStar TMS Therapy was established in a controlled clinical trial comparing active treatment with the NeuroStar TMS Therapy system to an inactive device. Patients treated with active NeuroStar TMS Therapy received an average reduction in their depression symptom score of 22.1% compared to a 9% average reduction in patients receiving inactive treatment (1).

NeuroStar TMS Therapy has not been studied in patients who have not received prior antidepressant treatment. Its effectiveness has also not been established in patients who have failed to receive benefit from two or more prior antidepressant medications at minimal effective dose and duration in the current episode.

The most common side effect associated with treatment is scalp pain or discomfort at or near the treatment site - generally mild to moderate (2). There is a rare risk of seizure with TMS Therapy.

NeuroStar TMS Therapy is available by prescription only. For full prescribing and safety information, please visit www.NeuroStar.com or call Neuronetics customer Service at 1-877-600-7555.

1. Demitrack MA, Thase, ME. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharm Bull. 2009, 42(2): 5-38.

2) Janicak P, et al. Transcranial Magnetic Stimulation (TMS) in the Treatment of Major Depression: A Comprehensive Summary of Safety Experience from Acute Exposure, Extended Exposure and During Reintroduction Treatment. Journal of Clinical Psychiatry, February 2008.

Category:

Science & Technology

Tags:

• Why Choose NeuroStar
• NeuroStar
• NeuroStar TMS Therapy
• TMS Therapy